Lathia Lab Research Featured in Nature Cancer 2023 in Review

headshot of Justin Lathia

Written by leading science researchers, editors, and journalists, reviews in Nature Cancer's 2023 in Review showcase the most exciting discoveries and the biggest challenges of the year. It's not surprising that research conducted in the lab run by Case CCC's Justin Lathia, PhD, Molecular Oncology Program leader, was cited.

The Lathia Lab's paper on mitochondria transfer (originally published in Nature Cancer) and work on the sex differences in T-cells (originally published in Cancer Discovery) were highlighted.

Read Nature Cancer’s 2023 in Review